Impact of False-Negative Sentinel Lymph Node Biopsy on Survival in Patients with Cutaneous Melanoma
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background and Objectives
Sentinel lymph node biopsy is widely accepted as standard care in melanoma despite lack of pertinent randomized trials results. A possible pitfall of this procedure is the inaccurate identification of the sentinel lymph node leading to biopsy and analysis of a nonsentinel node. Such a technical failure may yield a different prognosis. The purpose of this study is to analyze the incidence of false negativity and its impact on clinical outcome and to try to understand its causes.
The Melanoma Data Base at National Cancer Institute of Naples was analyzed comparing results between false-negative and tumor-positive sentinel node patients focusing on overall survival and prognostic factors influencing the clinical outcome.
One hundred fifty-one cases were diagnosed to be tumor-positive after sentinel lymph node biopsy and were subjected to complete lymph node dissection. Thirty-four (18.4%)patients with tumor-negative sentinel node subsequently developed lymph node metastases in the basin site of the sentinel procedure. With a median follow-up of 42.8 months the 5-year overall survival was 48.4% and 66.3% for false-negative and tumor-positive group respectively with significant statistical differences (P < .03).
The sensitivity of sentinel lymph node biopsy was 81.6%, and a regional nodal basin recurrence after negative-sentinel node biopsy means a worse prognosis, compared with patients submitted to complete lymph node dissection after a positive sentinel biopsy. The evidence of higher number of tumor-positive nodes after delayed lymphadenectomy in false-negative group compared with tumor-positive sentinel node cases, confirmed the importance of an early staging of lymph nodal involvement. Further data will better clarify the role of prognostic factors to identify cases with a more aggressive biological behavior of the disease.
- Gadd MA, Cosimi AB, Yu J, et al. Outcome of patients with melanoma and histological negative sentinel lymph nodes Arch Surg 1999; 134:381–7 CrossRef
- Scolyer RA, Thompson JF, Li LXL, et al. Failure to remove true sentinel nodes can cause failure of the sentinel node biopsy technique: evidence from antimony concentrations in false-negative sentinel nodes from melanoma patients Ann Surg Oncol 2004; 11:174s–8s
- Zogakis TG, Essner R, Wang H, Turner RR, Takasumi YT, Gaffney RL, et al. Melanoma recurrence patterns after negative sentinel lymphadenectomy Arch Surg 2005; 140:865–872 CrossRef
- Morton DL. Sentinel node mapping and an International Sentinel node Society: current issues and future directions Ann Surg Oncol 2004; 11:137s–43s
- Mozzillo N, Caracò C, Chiofalo MG, et al. Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-up Eur J Surg Oncol 2004; 30:440–3 CrossRef
- Yee VSK, Thompson JF, McKinnon JG, et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy Ann Surg Oncol 2005; 12:429–39 CrossRef
- Morton Dl, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 2006; 355:1307–17 CrossRef
- Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an International Multicenter Trial Ann Surg 2005; 242:302–11
- Thomas MJ. The place of sentinel node biopsy in melanoma after the multicenter selective lymphadenectomy trial ANZ J Surg 2006; 76:98–99 CrossRef
- McMaster KM. What good is sentinel lymph node biopsy for melanoma if it does not improve survival? Ann Surg Oncol 2004; 11:810–2 CrossRef
- Doubrovsky A, de Wilt JHW, Scolyer RA, et al. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma Ann Surg Oncol 2004; 11:829–36 CrossRef
- Thompson JF, Shaw HM. The prognosis of patients with thick primary melanomas: is regional lymph node status relevant, and does removing positive regional nodes influence the outcome Ann Surg Oncol 2002; 9:719–22
- Ferrone CR, Panageas KS, Busam K, et al. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel node status Ann Surg Oncol 2002; 9:637–45 CrossRef
- Caracò C, Celentano E, Lastoria S, et al. Sentinel lymph node biopsy does not change melanoma-specific survival in patients with Breslow thicker than 4 mm Ann Surg Oncol 2004; 11:263S–6S
- Impact of False-Negative Sentinel Lymph Node Biopsy on Survival in Patients with Cutaneous Melanoma
Annals of Surgical Oncology
Volume 14, Issue 9 , pp 2662-2667
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Cutaneous melanoma
- Sentinel biopsy
- Lymph node metastases
- Industry Sectors